The Peripheral Immune System and Amyotrophic Lateral Sclerosis

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by motor neuron loss and protein aggregation.
• Pathological changes extend beyond motor neurons, involving extra-motor brain regions, metabolism, and immune system abnormalities, including neuroinflammation.
• Peripheral immune system alterations, such as changes in T lymphocytes, monocytes, complement, and cytokines, are observed in ALS patients.

Purpose of the Study:

• To review emerging evidence implicating peripheral immune alterations in ALS pathogenesis.
• To explore the potential of these peripheral immune alterations as therapeutic targets for ALS.

Main Methods:

• Review of preclinical and clinical research on the role of the peripheral immune system in ALS.
• Analysis of existing data on immunomodulatory agents and their efficacy in ALS trials.

Main Results:

• Preclinical studies show strong evidence for benefit from immune modulation in ALS.
• Clinical trials of immunomodulatory agents have yielded mixed results, with some negative outcomes.
• Ongoing trials are investigating further the therapeutic potential of immune modulation in ALS.

Conclusions:

• Peripheral immune system alterations are increasingly implicated in the pathogenesis of ALS.
• Targeting the peripheral immune system represents a promising avenue for future therapeutic interventions in ALS.
• Further research and clinical trials are warranted to validate the efficacy of immunomodulatory strategies for ALS treatment.